These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18781939)

  • 1. LPA and its analogs-attractive tools for elucidation of LPA biology and drug development.
    Kano K; Arima N; Ohgami M; Aoki J
    Curr Med Chem; 2008; 15(21):2122-31. PubMed ID: 18781939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two pathways for lysophosphatidic acid production.
    Aoki J; Inoue A; Okudaira S
    Biochim Biophys Acta; 2008 Sep; 1781(9):513-8. PubMed ID: 18621144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LPA(3), a unique G protein-coupled receptor for lysophosphatidic acid.
    Hama K; Aoki J
    Prog Lipid Res; 2010 Oct; 49(4):335-42. PubMed ID: 20230855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of fluorinated lysophosphatidic acid analogues.
    Xu Y; Aoki J; Shimizu K; Umezu-Goto M; Hama K; Takanezawa Y; Yu S; Mills GB; Arai H; Qian L; Prestwich GD
    J Med Chem; 2005 May; 48(9):3319-27. PubMed ID: 15857137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidic acid (LPA) receptor modulators: Structural features and recent development.
    Meduri B; Pujar GV; Durai Ananda Kumar T; Akshatha HS; Sethu AK; Singh M; Kanagarla A; Mathew B
    Eur J Med Chem; 2021 Oct; 222():113574. PubMed ID: 34126459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorothioate analogs of sn-2 radyl lysophosphatidic acid (LPA): metabolically stabilized LPA receptor agonists.
    Jiang G; Inoue A; Aoki J; Prestwich GD
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1865-9. PubMed ID: 23395664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of anticancer lysophosphatidic acid agonists and antagonists.
    Parrill AL
    Future Med Chem; 2014 May; 6(8):871-83. PubMed ID: 24962280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of monofluorinated analogues of lysophosphatidic acid.
    Xu Y; Qian L; Prestwich GD
    J Org Chem; 2003 Jun; 68(13):5320-30. PubMed ID: 12816494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorothioate analogues of alkyl lysophosphatidic acid as LPA3 receptor-selective agonists.
    Qian L; Xu Y; Simper T; Jiang G; Aoki J; Umezu-Goto M; Arai H; Yu S; Mills GB; Tsukahara R; Makarova N; Fujiwara Y; Tigyi G; Prestwich GD
    ChemMedChem; 2006 Mar; 1(3):376-83. PubMed ID: 16892372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological roles of lysophosphatidic acid signaling through its production by autotaxin.
    Okudaira S; Yukiura H; Aoki J
    Biochimie; 2010 Jun; 92(6):698-706. PubMed ID: 20417246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophosphatidic acid and its receptors: pharmacology and therapeutic potential in atherosclerosis and vascular disease.
    Zhou Y; Little PJ; Ta HT; Xu S; Kamato D
    Pharmacol Ther; 2019 Dec; 204():107404. PubMed ID: 31472182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique ligand selectivity of the GPR92/LPA5 lysophosphatidate receptor indicates role in human platelet activation.
    Williams JR; Khandoga AL; Goyal P; Fells JI; Perygin DH; Siess W; Parrill AL; Tigyi G; Fujiwara Y
    J Biol Chem; 2009 Jun; 284(25):17304-17319. PubMed ID: 19366702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
    Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS
    Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural insights into ligand recognition by the lysophosphatidic acid receptor LPA
    Taniguchi R; Inoue A; Sayama M; Uwamizu A; Yamashita K; Hirata K; Yoshida M; Tanaka Y; Kato HE; Nakada-Nakura Y; Otani Y; Nishizawa T; Doi T; Ohwada T; Ishitani R; Aoki J; Nureki O
    Nature; 2017 Aug; 548(7667):356-360. PubMed ID: 28792932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation.
    Gueguen G; Gaigé B; Grévy JM; Rogalle P; Bellan J; Wilson M; Klaébé A; Pont F; Simon MF; Chap H
    Biochemistry; 1999 Jun; 38(26):8440-50. PubMed ID: 10387090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of extracellular lysophosphatidic acid in the regulation of adipocyte functions and liver fibrosis.
    Yang F; Chen GX
    World J Gastroenterol; 2018 Sep; 24(36):4132-4151. PubMed ID: 30271079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, pharmacology, and cell biology of sn-2-aminooxy analogues of lysophosphatidic acid.
    Gajewiak J; Tsukahara R; Fujiwara Y; Tigyi G; Prestwich GD
    Org Lett; 2008 Mar; 10(6):1111-4. PubMed ID: 18284246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidic acid-induced platelet shape change revealed through LPA(1-5) receptor-selective probes and albumin.
    Khandoga AL; Fujiwara Y; Goyal P; Pandey D; Tsukahara R; Bolen A; Guo H; Wilke N; Liu J; Valentine WJ; Durgam GG; Miller DD; Jiang G; Prestwich GD; Tigyi G; Siess W
    Platelets; 2008 Sep; 19(6):415-27. PubMed ID: 18925509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Edg family lysophosphatidic acid (LPA) receptors.
    Ishii S; Noguchi K; Yanagida K
    Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):57-65. PubMed ID: 19524700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal transduction responses to lysophosphatidic acid and sphingosine 1-phosphate in human prostate cancer cells.
    Gibbs TC; Rubio MV; Zhang Z; Xie Y; Kipp KR; Meier KE
    Prostate; 2009 Oct; 69(14):1493-506. PubMed ID: 19536794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.